Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies

(2010) Brunilde Gril et al.   EUROPEAN JOURNAL OF CANCER

Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studies

(2010) V. Surmont et al.   LUNG CANCER

CNS complications of radiotherapy and chemotherapy

(2009) Carole Soussain et al.   LANCET

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

(2009) Eric L Chang et al.   LANCET ONCOLOGY

Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lung

(2009) A. Omlin et al.   LUNG CANCER

Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer

(2009) Alessandra Bearz et al.   LUNG CANCER

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

(2008) Giorgio Vittorio Scagliotti et al.   JOURNAL OF CLINICAL ONCOLOGY